4.8 Article

Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2

期刊

NATURE COMMUNICATIONS
卷 13, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41467-022-28586-0

关键词

-

资金

  1. Ministry of Science and Technology (China) [2018YFA0507002]
  2. Shanghai Municipal Science and Technology Major Project [2019SHZDZX02]
  3. CAS Strategic Priority Research Program [XDB08020303]
  4. Special Research Assistant Project of Chinese Academy of Sciences [E1G707R078]
  5. National Institutes of Health (NIH) [1R03TR003306-01, 1R35GM128641]

向作者/读者索取更多资源

The study presents cryo-EM structures of formylpeptide receptors FPR1 and FPR2 bound to different agonists and Gi protein, providing insights into the recognition of formylpeptides and synthetic agonists by FPRs and their activation mechanism. This research has significant implications for the rational design of drugs targeting FPRs.
Zhuang et al. report four cryo-EM structures of formylpeptide receptors FPR1 and FPR2 coupled with Gi protein and diverse agonists, revealing how FPRs as pattern recognition receptors recognize formylpeptides and synthetic agonists and a distinctive receptor activation mechanism. The formylpeptide receptors (FPRs) mediate pattern recognition of formylated peptides derived from invading pathogens or mitochondria from dead host cells. They can also sense other structurally distinct native peptides and even lipid mediators to either promote or resolve inflammation. Pharmacological targeting of FPRs represents a novel therapeutic approach in treating inflammatory diseases. However, the molecular mechanisms underlying FPR ligand recognition are elusive. We report cryo-EM structures of G(i)-coupled FPR1 and FPR2 bound to a formylpeptide and G(i)-coupled FPR2 bound to two synthetic peptide and small-molecule agonists. Together with mutagenesis data, our structures reveal the molecular mechanism of formylpeptide recognition by FPRs and structural variations of FPR1 and FPR2 leading to their different ligand preferences. Structural analysis also suggests that diverse FPR agonists sample a conserved activation chamber at the bottom of ligand-binding pockets to activate FPRs. Our results provide a basis for rational drug design on FPRs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据